Over the past few years, Abbott Laboratories' (NYSE: ABT) business has been a bit of a roller coaster. The pandemic disrupted its medical device business, but it was later able to smooth out those ...

Abbott Laboratories’ Debt totaled $15 Bil at the end of the latest quarter, while its market capitalization stands at $233 ...

Abbott paved the way for the provision back in 2018 when it received a private letter ruling from the Internal Revenue Service allowing it to set up its own plan for entering employees into 401(k ...

Abbott Laboratories (ABT 0.51%) is a leading healthcare company with a global presence. It has a diverse business with four key segments: established pharmaceuticals, diagnostics, nutrition, and ...

AbbVie’s history stems from the late 19th-century work of Chicago physician Wallace Calvin Abbott, whose small operation of ...

Over the past few years, Abbott Laboratories' (ABT 0.16%) business has been a bit of a roller coaster. The pandemic disrupted its medical device business, but it was later able to smooth out those ...

Abbott Laboratories announced a plan to invest $500 million to expand its U.S. manufacturing footprint.. The medical device maker will upgrade facilities in both Illinois and Texas to expand its ...

Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the ...

Abbott Laboratories (NYSE: ABT). Q3 2024 Earnings Call. Oct 16, 2024, 9:00 a.m. ET. Read More: Earn up to $845 cash back this year just by changing how you pay at Costco! Learn more here.

Abbott Labs recently added a new product to this business that could help improve its performance. Let's review the details and find out what it all means for investors. The leader in continuous ...